XCeed appoints manufacturer
Friday, 11 June, 2004
Recently-listed XCeed Biotechnology (ASX:XBL) has announced that its subsidiary Polymerco will use Melbourne-based AorTech to manufacture its biodegradeable polyurethane. The product has applications in orthapaedics, wound repair, drug delivery and stents.
Aortech will stabilise and manufacture the biodegradeable polyurethane at its ISO certified Melbourne Australian Technology Centre. It currently manufactures biostable polyurethane Elast-Eon, used in medical devices.
In March, XCeed invested $5.1 million in Polymerco, taking a 50 per cent stake in the company. Polymerco was incorporated earlier this year to develop and commercialise CSIRO Molecular Science's biodegradable polymer technology.
Mouth bacteria linked to increased head and neck cancer risk
More than a dozen bacterial species that live in people's mouths have been linked to a...
Life expectancy gains are slowing, study finds
Life expectancy at birth in the world's longest-living populations has increased by an...
Towards safer epilepsy treatment for pregnant women
New research conducted in organoids is expected to provide pregnant women with epilepsy safer...